These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7865594)

  • 1. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine.
    Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K
    J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs.
    Blackall PJ; Asakawa T; Graydon RJ; White M; Adamson M; Wade LK; Lowe LB
    Aust Vet J; 1995 Jan; 72(1):35-6. PubMed ID: 8787526
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine.
    Moore GM; Basson RP; Tonkinson LV
    Am J Vet Res; 1996 Feb; 57(2):224-8. PubMed ID: 8633813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
    Shryock TR; Staples JM; DeRosa DC
    J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
    Blondeau JM; Fitch SD
    PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella choleraesuis isolates from pigs.
    Raemdonck DL; Tanner AC; Tolling ST; Michener SL
    Vet Rec; 1994 Jan; 134(1):5-7. PubMed ID: 8128570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibacterial activity of florfenicol against Actinobacillus pleuropneumoniae.
    Ueda Y; Suenaga I
    J Vet Med Sci; 1995 Apr; 57(2):363-4. PubMed ID: 7492665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
    Dayao D; Gibson JS; Blackall PJ; Turni C
    Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Hobson S; Lees P
    Res Vet Sci; 2017 Apr; 111():93-98. PubMed ID: 28113129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of doxycycline and oxytetracycline against porcine respiratory pathogens.
    Bousquet E; Morvan H; Aitken I; Morgan JH
    Vet Rec; 1997 Jul; 141(2):37-40. PubMed ID: 9253829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.
    Dorey L; Lees P
    BMC Vet Res; 2017 Jun; 13(1):192. PubMed ID: 28645327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?
    Dorey L; Hobson S; Lees P
    J Vet Pharmacol Ther; 2017 Oct; 40(5):517-529. PubMed ID: 28101885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotypes and antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from piglets with pleuropneumonia.
    Asawa T; Kobayashi H; Mitani K; Ito N; Morozumi T
    J Vet Med Sci; 1995 Aug; 57(4):757-9. PubMed ID: 8519914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral administration of tilmicosin on pulmonary inflammation in piglets experimentally infected with Actinobacillus pleuropneumoniae.
    Nerland EM; LeBlanc JM; Fedwick JP; Morck DW; Merrill JK; Dick P; Paradis MA; Buret AG
    Am J Vet Res; 2005 Jan; 66(1):100-7. PubMed ID: 15691043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens.
    Diarra MS; Malouin F; Jacques M
    Int J Antimicrob Agents; 1999 Aug; 12(3):229-37. PubMed ID: 10461841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of florfenicol for Actinobacillus pleuropneumoniae and Pasteurella multocida using standardised versus non-standardised methodology.
    Dorey L; Hobson S; Lees P
    Vet J; 2016 Dec; 218():65-70. PubMed ID: 27938711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Actinobacillus pleuropneumoniae, Actinobacillus suis, Haemophilus parasuis, Pasteurella multocida, and Streptococcus suis in representative Ontario swine herds.
    MacInnes JI; Gottschalk M; Lone AG; Metcalf DS; Ojha S; Rosendal T; Watson SB; Friendship RM
    Can J Vet Res; 2008 Apr; 72(3):242-8. PubMed ID: 18505187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental model of swine pneumonic pasteurellosis using crude Actinobacillus pleuropneumoniae cytotoxin and Pasteurella multocida given endobronchially.
    Chung WB; Bäckström LR; Collins MT
    Can J Vet Res; 1994 Jan; 58(1):25-30. PubMed ID: 8143249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy dose determination study of tilmicosin phosphate in feed for control of pneumonia caused by Actinobacillus pleuropneumoniae in swine.
    Moore GM; Mowrey DH; Tonkinson LV; Lechtenberg KF; Schneider JH
    Am J Vet Res; 1996 Feb; 57(2):220-3. PubMed ID: 8633812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Pasteurella haemolytica from cattle.
    Stephens CP; Blackall PJ; Wade LK; Lowe LB
    Aust Vet J; 1993 Oct; 70(10):391-2. PubMed ID: 8257321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.